Access to artemisinin combination therapy (ACT) remains low in most malaria endemic countries. A paper published in Malaria Journal indicates that the Affordable Medicines Facility-malaria (AMFm) will support interventions to address socio-economic barriers, strengthen regulatory systems, improve supply chains and improve quality of services as a means to improve access to life-saving ACT.

A major impediment to access to these life-saving medicines is unaffordable prices. The AMFm seeks to address the price barrier by drastically reducing the price of ACT. In addition to unaffordable prices, distance to facilities, locations of outlets and socio-economic status can hinder prompt and effective access to quality-assured ACT.

1. Matowe L, Adeyi O. The quest for universal access to effective malaria treatment: how can the AMFm contribute? Malaria Journal 2010; 9: 274. (open access)